Home/Pipeline/NVC-001A

NVC-001A

LMNA-related Dilated Cardiomyopathy

Phase 1Active

Key Facts

Indication
LMNA-related Dilated Cardiomyopathy
Phase
Phase 1
Status
Active
Company

About Nuevocor

Mechanobiology‑focused gene therapy company targeting rare cardiomyopathies.

View full company profile